Abstract:Background & Aims: Although CD8(+)T cell exhaustion hampers viral control during chronic HBV infection, the pool of CD8(+)T cells is phenotypically and functionally heterogeneous. Therefore, a specific subpopulation of CD8(+)T cells should be further investigated. This study aims to dissect a subset of CD8(+)T cells expressing C-X-C motif chemokine receptor 5 (CXCR5) in chronic HBV infection. Methods: The frequency of CXCR5(+)CD8(+)T cells and the levels of C-X-C motif chemokine ligand 13 (CXCL13), a chemokine of CXCR5, were measured in patients with chronic HBV infection. C57BL/6, interleukin (IL)-21 receptor- or B cell-deficient mice were hydrodynamically injected with pAAV-HBV1.2 plasmids. Phenotype and functions of peripheral and intrahepatic CXCR5(+) and CXCR5(-)CD8(+)T cells were assessed. Results: CXCR5(+)CD8(+)T cells were partially exhausted but possessed a stronger antiviral ability than the CXCR5(-) subset in patients with chronic HBV infection; moreover, CXCR5(+)CD8(+)T cells were associated with a favorable treatment response in patients with chronic hepatitis B (CHB). High levels of CXCL13 from patients with CHB facilitated the recruitment of intrahepatic CXCR5(+)CD8(+)T cells, and this subpopulation produced high levels of HBV-specific interferon (IFN)-gamma and IL-21. Notably, PD1 (programmed death 1) blockade and exogenous IL-21 enhanced the production of IFN-gamma. More strikingly, mice injected with CXCR5(+)CD8(+)T cells showed remarkably decreased expression of HBsAg. Additionally, an impaired production of HBV-specific IFN-gamma from intrahepatic CXCR5(+)CD8(+)T cells was observed in IL-21 receptor- or B cell-deficient mice. Conclusion: CXCL13 promotes the recruitment of CXCR5(+)CD8(+)T cells to the liver, and this subpopulation improves viral control in chronic HBV infection. The identification of this unique sub- population may contribute to a better understanding of CD8(+)T cell functions and provide a potential immunotherapeutic target in chronic HBV infection. Lay summary: Exhaustion of CD8(+)T cells is an important factor in the development of chronic hepatitis B virus (HBV) infection. CD8(+)T cells expressing the receptor CXCR5 are partially exhausted, but have potent antiviral activity, as they produce high levels of HBV-specific cytokines in chronic HBV infection. Increased expression of CXCL13 within the liver facilitates the recruitment of CXCR5(+)CD8(+)T cells and establishes effective immune control of HBV infection. (C) 2019 European Association for the Study of the Liver. Published by Elsevier B.V.

Circulating Chemokine (C-X-C Motif) Receptor 5+CD4+T Cells Benefit Hepatitis B E Antigen Seroconversion Through IL-21 in Patients with Chronic Hepatitis B Virus Infection

Seroconversion Through IL-21 in Patients with Chronic HBV Infection

Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control During Antiviral Therapy

High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B.

CXCL13-mediated Recruitment of Intrahepatic CXCR5+CD8+T Cells Favors Viral Control in Chronic HBV Infection.

Changes of Costimulatory Molecule CD28 on Circulating CD8+ T Cells Correlate with Disease Pathogenesis of Chronic Hepatitis B.

Interleukin 21 Reinvigorates The Antiviral Activity Of Hepatitis B Virus (Hbv)-Specific Cd8(+) T Cells In Chronic Hbv Infection

Complementarity-Determining Region 3 Size Spectratypes of T Cell Receptor Β Chains in CD8 + T Cells Following Antiviral Treatment of Chronic Hepatitis B

The Frequency and Skewed T-Cell Receptor Beta-Chain Variable Patterns of Peripheral Cd4(+)Cd25(+) Regulatory T-Cells Are Associated with Hepatitis B E Antigen Seroconversion of Chronic Hepatitis B Patients During Antiviral Treatment

Restored Circulating Invariant NKT Cells Are Associated with Viral Control in Patients with Chronic Hepatitis B.

HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients

Predictive Value of Serum ALT and T-cell Receptor Beta Variable Chain for HBeAg Seroconversion in Chronic Hepatitis B Patients During Tenofovir Treatment

Characteristics of T-cell subsets and serum cytokines in patients with chronic hepatitis B during different immune status and after antivirus treatment

Baseline Quantitative Hepatitis B Core Antibody Titre Alone Strongly Predicts HBeAg Seroconversion Across Chronic Hepatitis B Patients Treated with Peginterferon or Nucleos(t)ide Analogues.

IL-21-Deficient T Follicular Helper Cells Support B Cell Responses Through IL-27 in Patients With Chronic Hepatitis B

Increased Circulating T Follicular Helper Cells Induced Via IL-12/21 in Patients with Acute on Chronic Hepatitis B Liver Failure

Hepatitis B e Antigen Seroconversion Is Related with the Function of Dendritic Cells in Chronic Hepatitis B Virus Infection

Distinct T‐cell receptor profiles associated with hepatitis B e antigen seroconversion during entecavir treatment

HBV Promotes the Recruitment of IL‐17 Secreting T Cells Via Chemokines CCL22 and CCL17

Circulating and Liver Resident CD4+CD25+ Regulatory T Cells Actively Influence the Antiviral Immune Response and Disease Progression in Patients with Hepatitis B.

Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment